文献速递乳腺癌放疗

一天老十岁:早期乳腺癌辅助治疗分配中的年龄截断偏倚

Aging a Decade in a Day: Age Cutoff Bias in Adjuvant Therapy Allocation for Early-Stage Breast Cancer.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2023-01-31

研究利用美国国家癌症数据库2004至2017年间两个具有明确辅助治疗指征的早期乳腺癌队列,检验年龄截断启发式是否导致非循证的治疗分配。结果显示,放疗推荐率在70岁较69岁骤降(OR 0.47),内分泌治疗推荐率在70岁较69岁小幅下降(OR 0.86),提示医生可能将年龄作为二分类变量处理。

要点

  • 队列1中放疗推荐率在70岁较69岁骤降,仅70岁与69岁比较的year-over-year年龄差异为独立预测因子(OR 0.47,99.8%CI 0.39-0.57,P<.001)。
  • 队列2中内分泌治疗推荐率在70岁较69岁小幅下降,仅70岁与69岁比较的year-over-year年龄差异为预测因子(OR 0.86,99.8%CI 0.74-0.99,P=.001)。
  • 作者认为这提示在该人群中医生可能将年龄作为分类二变量处理,是早期乳腺癌中先前未被描述的现象。

核心结论

  • 在具有明确辅助治疗指征的早期乳腺癌患者中,观察到69岁至70岁之间适当的辅助治疗推荐出现独特下降。
  • 作者认为这提示在该人群中医生可能使用年龄截断启发式将年龄作为分类二变量处理,是早期乳腺癌中先前未被描述的现象。

研究设计与样本

  • 研究从美国国家癌症数据库(National Cancer Database)中识别2004年至2017年间因早期乳腺癌接受肿块切除术、且无论年龄均有强烈辅助治疗指征的两个队列。
  • 队列1具有较高风险特征(雌激素受体阴性、未计划内分泌治疗、最终切缘阳性或肿瘤>3 cm;n=160,990),适合放疗。
  • 队列2为激素受体阳性且肿瘤>5 mm(n=394,946),适合内分泌治疗。
  • 采用多变量逻辑回归(含比值比OR和99.8%置信区间CI)判断任何单一年龄的year-over-year差异是否独立与辅助治疗推荐可能性差异相关。

主要发现

  • 队列1中放疗推荐率在70岁急剧下降:50至69岁之间为90%至92%,70岁为81%。
  • 队列1多变量逻辑回归显示,仅70岁与69岁比较的year-over-year年龄差异是辅助放疗推荐的独立预测因子(OR 0.47;99.8%CI 0.39-0.57;P<.001)。
  • 队列2中内分泌治疗推荐率在70岁出现小幅下降,仅70岁与69岁比较的year-over-year年龄差异是内分泌治疗推荐的预测因子(OR 0.86;99.8%CI 0.74-0.99;P=.001)。

关键数值与推荐

  • 队列1放疗推荐率:50至69岁为90%至92%,70岁为81%。
  • 队列1中70岁 vs 69岁的OR为0.47(99.8%CI 0.39-0.57,P<.001)。
  • 队列2中70岁 vs 69岁的OR为0.86(99.8%CI 0.74-0.99,P=.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Physicians may expedite interpretation of data presented as a continuous variable by binning the data into "high" and "low" subgroups (cutoff heuristic). Use of this cognitive shortcut with age may lead to fewer nuanced or inappropriate decisions. We hypothesized an age cutoff heuristic may lead to non-evidence-based adjuvant treatment allocation among patients with early-stage breast cancer. METHODS AND MATERIALS: Two cohorts with strong indications for adjuvant treatment regardless of age that underwent lumpectomy for early-stage breast cancer between 2004 and 2017 were identified in the National Cancer Database. Cohort 1 had higher-risk features (estrogen receptor negative, endocrine therapy not planned, final margins positive, or size >3 cm; n = 160,990) and was appropriate for radiation. Cohort 2 had hormone receptor positivity with tumors >5 mm (n = 394,946) and was appropriate for endocrine therapy. Multivariable logistic regressions with odds ratios (ORs) and 99.8% confidence intervals (CIs) were performed to determine whether any single year-over-year age difference was independently associated with a difference in likelihood of adjuvant therapy recommendation. RESULTS: In cohort 1, radiation recommendation decreased sharply at age 70, ranging from 90% to 92% between the ages of 50 and 69 years to 81% for those aged 70 years. Multivariable logistic regressions showed year-over-year age difference was an independent predictor for adjuvant radiation recommendation at only age 70 versus 69 (OR, 0.47; CI, 0.39-0.57; P < .001). For cohort 2, endocrine therapy recommendation showed a small decline at age 70, and year-over-year age difference was a predictor of endocrine therapy recommendation at only age 70 versus 69 (OR, 0.86; CI, 0.74-0.99; P = .001). CONCLUSIONS: We observed a unique decline in appropriate adjuvant therapy recommendation between ages 69 and 70. This suggests use of an age cutoff heuristic to process patient age in this population as a categorical, binary variable. This is a previously undescribed phenomenon in early-stage breast cancer.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Talcott WJ, Cain DM, Yang D, et al. Aging a Decade in a Day: Age Cutoff Bias in Adjuvant Therapy Allocation for Early-Stage Breast Cancer. Int J Radiat Oncol Biol Phys. 2023. PMID: 37125983. doi:10.1016/j.ijrobp.2022.12.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。